The Latest Neurology Industry Statistics Explained
The global neurology devices market size was valued at USD 21.16 billion in 2018.
The statistic ‘The global neurology devices market size was valued at USD 21.16 billion in 2018’ indicates the total monetary value of medical devices specifically designed for neurological conditions worldwide in the year 2018. This figure represents the collective revenue generated by the sales of various neurology devices such as diagnostic equipment, therapeutic devices, and surgical instruments. The market size reflects the demand for neurology devices, which is influenced by factors like technological advancements, prevalence of neurological disorders, and increasing healthcare expenditure. Understanding this statistic is essential for stakeholders in the healthcare industry, including manufacturers, investors, and policymakers, to make informed decisions regarding research, development, and investment opportunities in the neurology devices market.
The North America Neurological Devices market is predicted to grow at a 7.3% Compound Annual Growth Rate (CAGR) between 2019 and 2024.
The statistic indicates that the market for neurological devices in North America is expected to experience a consistent annual growth rate of 7.3% over the period from 2019 to 2024. This Compound Annual Growth Rate (CAGR) prediction suggests that the industry is likely to expand steadily over the five-year period, reflecting increasing demand for neurological devices in the region. This projection could be influenced by factors such as technological advancements, rising prevalence of neurological disorders, and an aging population requiring more medical intervention for neurological conditions. Overall, the forecasted growth indicates a positive trajectory for the North America Neurological Devices market in the coming years.
The neurology workforce in the United States comprises less than 1% of all physicians.
This statistic indicates that the field of neurology is a small subset within the overall physician workforce in the United States, accounting for less than 1% of all practicing physicians. This suggests that neurologists are a relatively rare specialty compared to other medical disciplines. The limited number of neurologists may have implications for patient access to neurological care, potentially resulting in longer wait times for appointments or limited availability of specialized services. It also highlights the importance of efforts to recruit and retain neurologists in order to meet the growing demand for neurological care in the population.
In 2016, among the top 10 leading pharmaceutical companies worldwide, biogen generated around 94 percent of its revenues from neurology drugs.
The statistic indicates that in 2016, Biogen, one of the top 10 leading pharmaceutical companies globally, derived a significant proportion, around 94 percent, of its revenues from neurology drugs. This suggests that neurology drugs are a key focus area for Biogen and play a crucial role in the company’s financial performance. The high percentage of revenue generated from neurology drugs indicates that Biogen has a strong presence and expertise in this particular therapeutic area, possibly specializing in the development and marketing of drugs targeting neurological disorders. This statistic underscores the importance of neurology drugs to Biogen’s overall business strategy and revenue stream.
Among children and adolescents ages 0-19, neurology-related conditions resulted in nearly 12 million hospital stays & emergency department visits in 2012.
This statistic indicates the significant burden of neurology-related conditions among children and adolescents aged 0-19 in 2012. The phrase “nearly 12 million hospital stays & emergency department visits” highlights the substantial number of healthcare encounters related to neurology conditions experienced by this age group during that year. Neurology-related conditions may include a wide range of issues affecting the nervous system, such as epilepsy, headaches, developmental delays, and other neurological disorders. The high number of hospital visits and emergency department admissions underscores the importance of addressing and managing these conditions effectively in children and adolescents to improve their overall health outcomes and quality of life.
The World Health Organization estimates that neurological disorders, ranging from epilepsy to Alzheimer’s illness, affect up to one billion people worldwide.
The statistic provided by the World Health Organization highlights the profound impact of neurological disorders on a global scale. With an estimated one billion individuals affected worldwide, conditions such as epilepsy and Alzheimer’s disease represent significant public health challenges. These disorders can have wide-ranging effects on individuals, families, and communities, leading to disabilities, financial burdens, and reduced quality of life. The staggering number underscores the critical need for increased awareness, research, and support to address the prevention, treatment, and management of neurological disorders to improve the well-being of affected individuals and society as a whole.
A 2020 neurologist compensation report registered an average earning of $280,000 per year for U.S. neurologists.
The statistic from the 2020 neurologist compensation report indicates that the average annual earnings for U.S. neurologists was $280,000. This mean income level serves as a benchmark for understanding the general salary expectations within the field of neurology. It provides valuable insight into the financial compensation that neurologists in the United States typically receive for their specialized medical expertise and services. By examining this average earning figure, stakeholders such as neurologists themselves, healthcare institutions, policymakers, and researchers can better evaluate the economic landscape and financial considerations relevant to the neurology profession in the U.S.
7.7 million new cases of dementia are diagnosed each year, according to Alzheimer’s Disease International.
The statistic that 7.7 million new cases of dementia are diagnosed each year, according to Alzheimer’s Disease International, highlights the significant global burden of this condition. Dementia is a progressive neurodegenerative disorder that affects cognitive function, memory, and behavior, leading to a decline in the ability to perform daily activities. The high number of new diagnoses each year indicates the ongoing challenge presented by dementia on a global scale. This statistic emphasizes the pressing need for increased awareness, research, and support for individuals living with dementia, as well as their caregivers and families, to effectively address the growing impact of this condition on public health and society.
An estimated 6.8 million people in the United States have suffered a stroke.
The statistic ‘An estimated 6.8 million people in the United States have suffered a stroke’ indicates the prevalence and impact of strokes in the country. This number reflects the significant burden of stroke, a medical condition where blood flow to the brain is interrupted, leading to potentially severe neurological consequences. Strokes can result in disabilities, cognitive impairments, and even death, making it a critical public health concern. Understanding the scale of stroke prevalence can help healthcare providers, policymakers, and researchers allocate resources effectively for prevention, treatment, and rehabilitation efforts to improve outcomes and reduce the overall impact of strokes on individuals and society as a whole.
Hawaii has the highest rate of neurologists per 100,000 people in the USA.
The statistic stating that Hawaii has the highest rate of neurologists per 100,000 people in the USA indicates that Hawaii has a greater concentration of neurologists compared to the other states. This statistic is derived by comparing the number of practicing neurologists in Hawaii to its population size and expressing it per 100,000 people for easier comparison across states. The high rate of neurologists suggests that residents in Hawaii may have better access to neurological care and expertise compared to residents in other states with lower rates of neurologists per 100,000 people. This statistic highlights a potential advantage in healthcare infrastructure and resources for neurological care in Hawaii.
On average, neurology procedures were the most expensive type of hospital stay, at more than $32,000 per stay in the US.
The statistic states that, on average, the cost of neurology procedures in hospital stays is the highest among all types of hospital stays in the US, with an average cost exceeding $32,000 per stay. This indicates that neurology procedures are associated with significant healthcare costs compared to other types of medical treatments and services. The relatively high cost of neurology procedures may be attributed to various factors such as the specialized expertise and equipment required, the complexity of neurological conditions, extensive diagnostic testing and imaging, as well as the length of hospitalization and follow-up care involved. The statistic highlights the financial burden that neurology procedures can impose on individuals, healthcare systems, and insurers, emphasizing the importance of understanding and managing the costs associated with such services to ensure access to quality neurology care while maintaining affordability and sustainability in healthcare delivery.
In 2018, approximately 50 million people worldwide had epilepsy, making it one of the most common neurological diseases globally.
The statistic states that in 2018, around 50 million individuals globally were living with epilepsy, which is a neurological disorder characterized by recurrent seizures. This statistic highlights the significant impact of epilepsy as one of the most prevalent neurological conditions worldwide. The sheer number of individuals affected emphasizes the importance of understanding, treating, and managing epilepsy effectively. By shedding light on the widespread nature of epilepsy, this statistic underscores the need for increased awareness, research, and support for individuals living with this condition to improve their quality of life and reduce the associated stigma and challenges.
The number of epilepsy patients has risen by 30 per cent since 1990 according to a Lancet Study.
The statistic indicates that there has been a 30% increase in the number of epilepsy patients since 1990 as reported in a study published in the Lancet. This suggests a significant rise in the prevalence of epilepsy over the last three decades. The increase in the number of epilepsy patients may be attributed to various factors such as improved diagnostic methods, increased awareness leading to more individuals seeking medical help, changes in lifestyle and environmental factors, as well as potential genetic predispositions. The findings highlight the growing public health concern associated with epilepsy and the need for increased resources, research, and intervention strategies to effectively manage and address the needs of individuals living with epilepsy.
Alzheimer’s disease and other dementias are projected to cost the U.S. $290 billion in 2019.
This statistic indicates the projected economic burden of Alzheimer’s disease and other dementias on the United States in the year 2019, estimated at $290 billion. This cost encompasses a variety of expenses, including medical care, long-term care, and the lost productivity of both individuals affected by the diseases and their caregivers. The significant financial impact highlights the need for increased funding for research, support services, and public health initiatives aimed at preventing and managing these conditions. Additionally, it underscores the importance of raising awareness and implementing policies to address the growing prevalence of Alzheimer’s disease and other dementias in an aging population.
By 2040, it’s estimated there will need to be at least 3,400 additional neurologists to meet US patient needs.
This statistic indicates that as the population ages and the prevalence of neurological conditions increases, there will be a growing demand for neurologists in the United States. The estimate of needing at least 3,400 additional neurologists by 2040 highlights the projected shortage in healthcare providers specializing in neurology to meet the needs of patients requiring neurological care. This shortfall could potentially lead to longer wait times for appointments, reduced access to specialized care, and increased strain on existing healthcare systems. Proactive measures, such as increasing training programs for neurologists and implementing telemedicine solutions, may be necessary to address this anticipated shortage and ensure that patients receive timely and quality neurological care in the future.
Approximately one in every six people worldwide suffers from a neurological disorder.
The statistic that approximately one in every six people worldwide suffers from a neurological disorder highlights the substantial global impact of these conditions on human health. Neurological disorders encompass a wide range of conditions affecting the brain, spinal cord, and nerves, such as Alzheimer’s disease, stroke, epilepsy, and Parkinson’s disease. The prevalence of these disorders underscores the significant burden they place on individuals, families, healthcare systems, and society as a whole. Increased awareness, research, and access to appropriate care and support are essential to addressing the challenges posed by neurological disorders and improving the quality of life for those affected.
As of 2020, the World Health Organization estimated that migraine affects approximately two in ten women, and one in twenty men.
The statistic provided indicates that as of 2020, the World Health Organization estimated the prevalence of migraine, a neurological condition characterized by severe headaches, to be higher in women compared to men. Specifically, the estimate suggests that approximately 20% of women experience migraines, while only 5% of men are affected. This gender disparity in migraine prevalence is a common observation in epidemiological studies and may be influenced by various factors such as hormonal differences, genetic predispositions, and societal factors. Understanding the differential burden of migraines between genders is important for healthcare practitioners to tailor effective interventions and support for individuals affected by this debilitating condition.
A study found that one in four Neurologists report burnout due to the increasing demands of the job.
The statistic revealed that a considerable portion of neurologists, specifically one out of every four, experience burnout as a consequence of the escalating pressures associated with their profession. Burnout is a state of emotional, physical, and mental exhaustion caused by long-term exposure to demanding work conditions. In the case of neurologists, the intricacies and high stakes of diagnosing and treating neurological disorders, coupled with heavy workloads, can lead to burnout. This finding highlights a significant issue within the neurology field, calling for attention to be paid to the well-being and mental health of these healthcare professionals in order to ensure the delivery of quality care to patients and the retention of skilled practitioners in the field.
References
0. – https://www.www.ncbi.nlm.nih.gov
1. – https://www.www.medscape.com
2. – https://www.www.cdc.gov
3. – https://www.www.nlm.nih.gov
4. – https://www.www.alz.org
5. – https://www.www.who.int
6. – https://www.www.alz.co.uk
7. – https://www.www.mdlinx.com
8. – https://www.hcup-us.ahrq.gov
9. – https://www.www.biogen.com
10. – https://www.www.statista.com
11. – https://www.www.aan.com
12. – https://www.www.grandviewresearch.com
13. – https://www.www.mordorintelligence.com
